CD4 and myeloid sarcoma: Specifically, FoxP3+CD25+CD4+ Tregs acquired notable attention because of their role in a variety of central nervous system (CNS) and autoimmune pathologies, such as multiple sclerosis (MS), stroke, and glioblastomas [9–13].